WHO halts malaria drug in COVID-19 trials
Embed this video
Share
Description
The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. This report produced by Jillian Kitchener.
General Info
UploadedJul 04, 2020
watch more videos